From January 1, 2023 to March 31, 2023, the company has repurchased 125,250 shares, representing 0.14% for CNY 6.48 million. With this, the company has completed the repurchase of 2,643,924 shares, representing 2.88% for CNY 156.49 million under the buyback announced on September 6, 2022.
Beijing Hotgen Biotech Co., Ltd.
Equities
688068
CNE100003P82
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.55 CNY | -1.50% | -8.66% | -28.01% |
04-29 | Beijing Hotgen Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-16 | Beijing Hotgen Biotech to Buy Kaijing Gene Technology for 11 Million Yuan | MT |
1st Jan change | Capi. | |
---|---|---|
-28.01% | 366M | |
-4.98% | 182B | |
+2.84% | 112B | |
-2.68% | 68.58B | |
+4.53% | 51.58B | |
+8.00% | 44.24B | |
+9.65% | 43.65B | |
+25.30% | 32.46B | |
-0.17% | 25.61B | |
+21.57% | 25.99B |
- Stock Market
- Equities
- 688068 Stock
- News Beijing Hotgen Biotech Co., Ltd.
- Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on September 6, 2022.